Department of Orthopedic, Trauma and Reconstructive Surgery, Percy Military Hospital, Clamart, France.
French Military Health Service Academy, Ecole du Val-de-Grâce, Paris, France.
Clin Orthop Relat Res. 2021 Dec 1;479(12):2737-2751. doi: 10.1097/CORR.0000000000001939.
Usually, the two-stage Masquelet induced-membrane technique for extremity reconstruction begins with a polymethylmethacrylate (PMMA) cement spacer-driven membrane, followed by an autologous cancellous bone graft implanted into the membrane cavity to promote healing of large bone defects. In exceptional cases, spacers made of polypropylene disposable syringes were successfully used instead of the usual PMMA spacers because of a PMMA cement shortage caused by a lack of resources. However, this approach lacks clinical evidence and requires experimental validation before being recommended as an alternative to the conventional technique.
QUESTIONS/PURPOSES: To (1) develop and (2) validate a critical-sized femoral defect model in rats for two stages of the Masquelet technique and to (3) compare the biological and bone healing properties of polypropylene-induced membranes and PMMA-induced membranes in this model.
Fifty male Sprague Dawley rats aged 8 weeks old received a 6-mm femur defect, which was stabilized with an external fixator that was converted into an internal device. In the development phase, the defect was filled with PMMA in 16 rats to determine the most favorable timing for bone grafting. Two rats were excluded since they died of anesthetic complications. The other 14 were successively euthanized after 2 weeks (n = 3), 4 weeks (n = 4), 6 weeks (n = 4), and 8 weeks (n = 3) for induced membrane analyses. In the validation phase, 12 rats underwent both stages of the procedure using a PMMA spacer and were randomly assigned to two groups, whether the induced membrane was preserved or removed before grafting. To address our final objective, we implanted either polypropylene or PMMA spacers into the defect (Masquelet technique Stage 1; n = 11 rats per group) for the period established by the development phase. In each group, 6 of 11 rats were euthanized to compare the biological properties of polypropylene-induced membranes and PMMA-induced membranes using histological qualitative analysis, semiquantitative assessment of the bone morphogenic protein-2 content by immunostaining, and qualitative assessment of the mesenchymal stromal cell (MSC; CD31-, CD45-, CD90+, and CD73+ phenotypes) content by flow cytometry. Quantitative measurements from serum bone turnover markers were also performed. The five remaining rats of each group were used for Masquelet technique Stage 2, in which rat bone allografts were implanted in the induced membrane cavity after the polypropylene or PMMA spacers were removed. These rats recovered for 10 weeks before being euthanized for microCT quantitative measurements and bone histology qualitative assessment to evaluate and compare the extent of bone regeneration between groups.
Induced membrane analyses together with serum bone turnover measurements indicated that a 4-week interval time between stages was the most favorable. Removal of the induced membrane before grafting led to almost constant early implant failures with poor bone formation. Four-week-old rats with polypropylene-triggered induced membranes displayed similar histologic organization as rats with PMMA-driven induced membranes, without any difference in the cell density of the extracellular matrix (4933 ± 916 cells per mm2 for polypropylene versus 4923 ± 1284 cells per mm2 for PMMA; p = 0.98). Induced membrane-derived MSCs were found in both groups with no difference (4 of 5 with polypropylene versus 3 of 3 with PMMA; p > 0.99). Induced membrane bone morphogenic protein-2 immunolabeling and serum bone turnover marker levels were comparable between the polypropylene and PMMA groups. MicroCT analysis found that bone regeneration in the polypropylene group seemed comparable with that in the PMMA group (29 ± 26 mm3 for polypropylene versus 24 ± 18 mm3 for PMMA; p > 0.99). Finally, qualitative histological assessment revealed a satisfactory endochondral ossification maturation in both groups.
Using a critical-sized femoral defect model in rats, we demonstrated that polypropylene spacers could induce membrane encapsulation with histologic characteristics and bone regenerative capacities that seem like those of PMMA spacers.
In a same bone site, polymers with close physical properties seem to lead to similar foreign body reactions and induce encapsulating membranes with comparable bone healing properties. Polypropylene spacers made from disposable syringes could be a valuable alternative to PMMA. These results support the possibility of a cementless Masquelet technique in cases of PMMA shortage caused by a lack of resources.
通常,二阶段 Masquelet 诱导膜技术用于四肢重建,开始时使用聚甲基丙烯酸甲酯(PMMA)水泥间隔物驱动的膜,然后将同种异体松质骨移植物植入膜腔中,以促进大骨缺损的愈合。在特殊情况下,由于资源缺乏导致 PMMA 水泥短缺,成功地使用了由一次性聚丙烯注射器制成的间隔物代替通常的 PMMA 间隔物。然而,这种方法缺乏临床证据,需要在推荐作为常规技术的替代方法之前进行实验验证。
问题/目的:(1)开发和(2)验证大鼠两阶段 Masquelet 技术的临界尺寸股骨缺损模型,并(3)比较在该模型中聚丙烯诱导膜和 PMMA 诱导膜的生物和骨愈合特性。
50 只 8 周龄雄性 Sprague Dawley 大鼠接受 6mm 股骨缺损,用外固定器稳定,外固定器转换为内装置。在发展阶段,16 只大鼠的缺损中填充 PMMA,以确定最佳的植骨时间。由于麻醉并发症,2 只大鼠死亡,被排除在外。其余 14 只大鼠分别在 2 周(n=3)、4 周(n=4)、6 周(n=4)和 8 周(n=3)后相继安乐死,用于诱导膜分析。在验证阶段,12 只大鼠使用 PMMA 间隔物进行两阶段手术,并随机分为两组,在植骨前是否保留或去除诱导膜。为了达到我们的最终目标,我们将聚丙乙烯或 PMMA 间隔物植入缺损(Masquelet 技术阶段 1;每组 n=11 只大鼠),时间由发展阶段确定。在每组中,11 只大鼠中的 6 只被安乐死,通过组织学定性分析、免疫染色检测骨形态发生蛋白-2 含量的半定量评估以及流式细胞术定性评估间充质基质细胞(CD31-、CD45-、CD90+和 CD73+表型)含量,比较聚丙乙烯诱导膜和 PMMA 诱导膜的生物学特性。还进行了血清骨转换标志物的定量测量。每组其余的 5 只大鼠用于 Masquelet 技术阶段 2,在去除聚丙乙烯或 PMMA 间隔物后,将大鼠同种异体移植物植入诱导膜腔。这些大鼠恢复 10 周后,进行 microCT 定量测量和骨组织学定性评估,以评估和比较各组之间的骨再生程度。
诱导膜分析结合血清骨转换标志物测量表明,两阶段之间 4 周的间隔时间是最有利的。在植骨前去除诱导膜导致早期植入物几乎持续失败,骨形成不良。使用聚丙乙烯触发的诱导膜的 4 周龄大鼠显示出与 PMMA 驱动的诱导膜相似的组织学结构,细胞外基质的细胞密度没有差异(聚丙乙烯为 4933±916 个细胞/mm2,PMMA 为 4923±1284 个细胞/mm2;p=0.98)。两组均发现诱导膜来源的 MSC,无差异(聚丙乙烯 4/5,PMMA 3/3;p>0.99)。诱导膜骨形态发生蛋白-2 免疫标记和血清骨转换标志物水平在聚丙乙烯组和 PMMA 组之间无差异。microCT 分析发现,聚丙乙烯组的骨再生似乎与 PMMA 组相当(聚丙乙烯为 29±26mm3,PMMA 为 24±18mm3;p>0.99)。最后,定性组织学评估显示两组均有满意的软骨内骨化成熟。
使用大鼠临界尺寸股骨缺损模型,我们证明了聚丙乙烯间隔物可以诱导膜包封,具有组织学特征和骨再生能力,类似于 PMMA 间隔物。
在同一骨部位,具有相似物理特性的聚合物似乎会引起类似的异物反应,并诱导具有相似骨愈合特性的包裹膜。由一次性注射器制成的聚丙乙烯间隔物可以作为 PMMA 的有价值的替代品。这些结果支持在由于资源缺乏导致 PMMA 短缺的情况下,采用无水泥 Masquelet 技术的可能性。